From Research to Recommendation 

We believe in the scientific clarity that comes from careful analysis of all available data. To offer clinical guidance and perform our comparative analyses, we draw upon the most recent, high quality clinical data. The result is a comprehensive, precise, and accurate comparison of therapeutic choices to provide patients and clinicians with the best available evidence.

Our analyses cover a variety of therapeutic areas, including psychiatric disorders, cardiometabolic disorders, neurology, pediatrics, pain, and infectious disease. We customize our analyses to answer the questions posed by our clients.

Recent Analysis

Mobirise Website Builder

Multiple Sclerosis Survey

Multiple sclerosis (MS) is a degeneration neurological condition that can impact all aspects of a person's life. We polled 350 people across the United States on their views of MS, including which symptoms they believe are the most significant and how they would try to learn more about the disease.
Mobirise Website Builder

Depression Survey

Depression is a serious mental illness that impacts the lives of millions of Americans. We asked people from across the country about their experience with depression, which symptoms they believe are the most debilitating, and their thoughts on the challenges of managing the disease.
Mobirise Website Builder

Clinical Trial Transparency

Access to the all clinical data is an important part of evidence-based medicine. But despite publication guidelines and best practices, many clinical trials sponsored by industry remain unpublished. We reviewed clinical trials and publication databases to determine publication rates across therapeutic areas.
Mobirise Website Builder

Type 2 Diabetes

There are plenty of therapies available, but no two treatments are the same. We analyzed efficacy measures from recent label claims of type 2 diabetes treatments to determine which compounds had the greatest impact across multiple outcomes.
Mobirise Website Builder

Bipolar Disorder

Lithium has been used in bipolar disorder for years, but our understanding of dosing may require another look. We reviewed clinical trials and treatment guidelines to determine how to balance efficacy and safety in adult patients.
Mobirise Website Builder

Child Psychiatry

Atypical antipsychotics are widely used in young patients, but these drugs are associated with with adverse events. We studied recent data to find out how available compounds affect weight in pediatric patients.

More projects are underway at IEBM. We're working on a CNS survey, a literature review, and an expansion of our 2016 ISMPP clinical trials study to other therapeutic areas.

Contact Philip Sjostedt to learn more about our process, our analyses, and how we can answer your questions.

Links

LinkedIn

Recent Analyses

MS Survey
Depression Survey
Clinical Trials

Contact

philip.sjostedt@systemenerveuxbio.com

+1 215-869-5252

30 W. Bridge Street, Suite 4
New Hope, PA 18938

Offline Website Builder